PSYCHOSIS IN PARKINSON'S DISEASE PATIENTS

被引:0
作者
Rahman, Abdul Hamid Abdul [1 ]
Abu Samah, Ibrahim [2 ]
Saini, Suriati Mohamed [1 ]
机构
[1] UKMMC, Dept Psychiat, Kuala Lumpur 56000, Malaysia
[2] Hosp Muar, Dept Psychiat & Mental Hlth, Muar, Malaysia
来源
ASEAN JOURNAL OF PSYCHIATRY | 2013年 / 14卷 / 02期
关键词
Psychosis; Parkinson; Associated Factors;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The objective of this study is to determine the prevalence and factors associated with psychosis in Parkinson's disease (PD) patients. Method: This is a cross-sectional study of 108 PD patients from neurological clinic UKM Medical Centre and Kuala Lumpur Hospital. The patients were recruited from August to December 2004. Psychosis was determined using SCID, the severity of psychosis was rated using BPRS. The cognitive functions were evaluated with MMSE and the severity of depression was assessed with HAM-D. Results: The result shows that the prevalence of psychosis in Parkinson's disease patients in this sample was 13%. The psychosis was found to be significantly associated with advancing age, duration of illness, severity of depression and cognitive impairment. Multivariate analysis demonstrates that severity of depression (OR = 1.08, 95% C.I. = 1.01 - 1.16) and advancing age (OR = 4.72, 95% C.I. = 1.37 - 16.29) increased risk of psychosis in PD patients. Conclusion: We found that advancing age and severity of depression increase risk to develop psychosis in patients with PD.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 50 条
[21]   Hallucinations and the spectrum of psychosis in Parkinson's disease [J].
Frei, Karen ;
Truong, Daniel D. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 374 :56-62
[22]   Cannabidiol for the treatment of psychosis in Parkinson's disease [J].
Zuardi, A. W. ;
Crippa, J. A. S. ;
Hallak, J. E. C. ;
Pinto, J. P. ;
Chagas, M. H. N. ;
Rodrigues, G. G. R. ;
Dursun, S. M. ;
Tumas, V. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (08) :979-983
[23]   Management of Hallucinations and Psychosis in Parkinson's Disease [J].
Eng, Marty L. ;
Welty, Timothy E. .
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2010, 8 (04) :316-330
[24]   Treatment of Psychosis and Dementia in Parkinson’s Disease [J].
Jennifer G. Goldman ;
Samantha Holden .
Current Treatment Options in Neurology, 2014, 16
[25]   Ziprasidone in the treatment of Parkinson's disease psychosis [J].
Shiah, I-Shin ;
Lin, Chun-Lung ;
Mao, Wei-Chung ;
Luu, Sy-Ueng .
EUROPEAN PSYCHIATRY, 2006, 21 (08) :578-579
[26]   Current Understanding of Psychosis in Parkinson’s Disease [J].
Oluwadamilola O. Ojo ;
Hubert H. Fernandez .
Current Psychiatry Reports, 2016, 18
[27]   Current Understanding of Psychosis in Parkinson's Disease [J].
Ojo, Oluwadamilola O. ;
Fernandez, Hubert H. .
CURRENT PSYCHIATRY REPORTS, 2016, 18 (10)
[28]   Aripiprazole in patients with psychosis associated with Parkinson's disease: Two case reports [J].
Yilmaz, Onur ;
Ates, Mehmet Alpay ;
Algul, Ayhan .
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 :S159-S161
[29]   Treatment of drug-induced psychosis in patients with Parkinson's disease. [J].
Lublin, H .
NORDIC JOURNAL OF PSYCHIATRY, 1997, 51 :57-63
[30]   Pattern of cognitive impairment in patients with Parkinson's disease and psychosis: A critical review [J].
Lenka, Abhishek ;
Hegde, Shantala ;
Arumugham, Shyam Sundar ;
Pal, Pramod Kumar .
PARKINSONISM & RELATED DISORDERS, 2017, 37 :11-18